After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Elanco Animal Health Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Elanco Animal Health Inc is $10.97B. A total of 4.52 million shares were traded on the day, compared to an average of 5.45M shares.
In the most recent transaction, Kurzius Lawrence Erik bought 10,000 shares of ELAN for 21.30 per share on Dec 12 ’25. After the transaction, the Director now owns 131,773 company shares. In a previous transaction on Dec 11 ’25, Modi Rajeev A. bought 4,500 shares at 21.33 per share. ELAN shares that the insider owns now total 123,082.
Among the insiders who bought shares, VanHimbergen Robert M acquired of 6,950 shares on Dec 11 ’25 at a per-share price of $21.64. This resulted in the EVP and CFO holding 124,233 shares of ELAN after the transaction. In another insider transaction, Simmons Jeffrey N bought 22,000 shares at $21.75 per share on Dec 11 ’25. Company shares held by the PRESIDENT, CEO AND DIRECTOR now total 167,000.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ELAN has a high of $23.70 and a low of $8.02.
As of this writing, ELAN has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.13 per share and a lower estimate of $0.1. The company reported an EPS of $0.14 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ELAN’s latest balance sheet shows that the firm has $638.00M in Cash & Short Term Investments as of fiscal 2021. There were $6.32B in debt and $1.65B in liabilities at the time. Its Book Value Per Share was $13.58, while its Total Shareholder’s Equity was $7.51B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELAN is Buy with a score of 4.60.
